Skip to content
value.today

ACCUDIAL Pharmaceutical INC

Formerly ACCUDIAL INC

Total raised
$12 M
3 rounds on record
Latest round
$2 M
May 2013
First round on record
Mar 2008
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ACCUDIAL Pharmaceutical INC
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2013$2 MNo. 3$2 to $10 million

ACCUDIAL Pharmaceutical INC: Raise no. 3, May 2013

Investors in this round

11 investors had bought by the notice of May 30, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Simons · Executive Officer
  • Terri Wescott · Executive Officer
  • Bradley B Eavenson · Director
  • Brian K Kaplan · Director, Promoter
  • David B Sotnick · Director
  • Neal B Pomroy · Director
  • Steve B Ziskind · Director
  • Robert Terwilliger · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Barry Simons, President. Source: SEC Form D, newest notice filed May 30, 2013. Read the notice at the SEC.

equitySEC
Apr 2011$5 MNo. 2$2 to $10 million

ACCUDIAL Pharmaceutical INC: Raise no. 2, Apr 2011

Investors in this round

61 investors had bought by the notice of Oct 16, 2012: 61 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $13 M offered; $8 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard J Haskins · Executive Officer, Director, Promoter
  • Robert K. Terwilliger · Executive Officer, Director, Promoter
  • Bradley B Eavenson · Director
  • Brian K. Kaplan · Director, Promoter
  • Carmen A Priore, III · Director
  • Kevin J Kelleher · Director
  • Mark D Kairalla · Director
  • Matthew J. O'Connor · Director
  • Patrick J. Lonergan · Director
  • Schuyler J Baab · Director
  • Stephen J Key · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Salary to executive officers as such compensation is described in more detail in the Regulation D Private Placment Memorandum, as supplemented, which is provided to an accredited investror before subscribing.”

Signed by Bradley B. Eavenson, Director. Source: SEC Form D, newest notice filed Oct 16, 2012. Read the notice at the SEC.

equity, optionsSEC
Mar 2008$5 MNo. 1$2 to $10 million

ACCUDIAL Pharmaceutical INC: Raise no. 1, Mar 2008

Investors in this round

57 investors had bought by the notice of May 27, 2010: 57 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $2 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$975,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard J Haskins · Executive Officer, Director, Promoter
  • Robert K. Terwilliger · Executive Officer, Director, Promoter
  • Bradley B Eavenson · Director
  • Brian K. Kaplan · Director, Promoter
  • Christopher T. Metz · Director
  • Mark D Kairalla · Director
  • Matthew J. O'Connor · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Salary to executive officers and compensation to directors as set forth in the Regulation D Private Placment Memorandum which is provided to an accredited investror before subscribing.”

Signed by Bradley B. Eavenson, Director. Source: SEC Form D and 1 amendment, newest notice filed May 27, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ACCUDIAL Pharmaceutical INC chose not to state its revenue in its newest notice of a funding round (May 2013).

    SEC Form D · May 2013

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2013

That is all the official record says: ACCUDIAL Pharmaceutical INC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of ACCUDIAL Pharmaceutical INC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 61 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ACCUDIAL Pharmaceutical INC
NameRoleNamed in
Barry SimonsExecutive officerMay 2013
Terri WescottExecutive officerMay 2013
Richard J HaskinsExecutive officerOct 2012
Robert K. TerwilligerExecutive officerOct 2012
Robert TerwilligerExecutive officerApr 2009
Bradley B EavensonDirectorMay 2013
Brian K KaplanDirectorMay 2013
David B SotnickDirectorMay 2013
Neal B PomroyDirectorMay 2013
Steve B ZiskindDirectorMay 2013
Brian K. KaplanDirectorOct 2012
Carmen A Priore, IIIDirectorOct 2012
Kevin J KelleherDirectorOct 2012
Mark D KairallaDirectorOct 2012
Matthew J. O'ConnorDirectorOct 2012
Patrick J. LonerganDirectorOct 2012
Richard J HaskinsDirectorOct 2012
Robert K. TerwilligerDirectorOct 2012
Schuyler J BaabDirectorOct 2012
Stephen J KeyDirectorOct 2012
Christopher T. MetzDirectorMay 2010
Robert TerwilligerDirectorApr 2009
Brian K KaplanPromoterMay 2013
Robert TerwilligerPromoterMay 2013
Brian K. KaplanPromoterOct 2012
Richard J HaskinsPromoterOct 2012
Robert K. TerwilligerPromoterOct 2012